Dr Reddy's Laboratories is planning to pour USD 300 million on research and development (R&D) during FY20. The R&D spend for Q4/FY19 stands at Rs 366 crore.
The company will continue to focus on R&D for some pipeline of proprietary products. But on an overall basis the R&D spend will be lower in proprietary products when compared to FY19.
The company has made R&D organisation more efficient and can handle more products with less cost, and it will continue with this plan of productivity to increase the R&D in order to ensure no fallbacks and no differentiated products.
The company during FY20 expects to launch more than 30 products in the US market.